ProMACE-MOPP regimen

Revision as of 14:54, 31 March 2015 by Aparna Vuppala (talk | contribs)
Jump to navigation Jump to search

WikiDoc Resources for ProMACE-MOPP regimen

Articles

Most recent articles on ProMACE-MOPP regimen

Most cited articles on ProMACE-MOPP regimen

Review articles on ProMACE-MOPP regimen

Articles on ProMACE-MOPP regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on ProMACE-MOPP regimen

Images of ProMACE-MOPP regimen

Photos of ProMACE-MOPP regimen

Podcasts & MP3s on ProMACE-MOPP regimen

Videos on ProMACE-MOPP regimen

Evidence Based Medicine

Cochrane Collaboration on ProMACE-MOPP regimen

Bandolier on ProMACE-MOPP regimen

TRIP on ProMACE-MOPP regimen

Clinical Trials

Ongoing Trials on ProMACE-MOPP regimen at Clinical Trials.gov

Trial results on ProMACE-MOPP regimen

Clinical Trials on ProMACE-MOPP regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on ProMACE-MOPP regimen

NICE Guidance on ProMACE-MOPP regimen

NHS PRODIGY Guidance

FDA on ProMACE-MOPP regimen

CDC on ProMACE-MOPP regimen

Books

Books on ProMACE-MOPP regimen

News

ProMACE-MOPP regimen in the news

Be alerted to news on ProMACE-MOPP regimen

News trends on ProMACE-MOPP regimen

Commentary

Blogs on ProMACE-MOPP regimen

Definitions

Definitions of ProMACE-MOPP regimen

Patient Resources / Community

Patient resources on ProMACE-MOPP regimen

Discussion groups on ProMACE-MOPP regimen

Patient Handouts on ProMACE-MOPP regimen

Directions to Hospitals Treating ProMACE-MOPP regimen

Risk calculators and risk factors for ProMACE-MOPP regimen

Healthcare Provider Resources

Symptoms of ProMACE-MOPP regimen

Causes & Risk Factors for ProMACE-MOPP regimen

Diagnostic studies for ProMACE-MOPP regimen

Treatment of ProMACE-MOPP regimen

Continuing Medical Education (CME)

CME Programs on ProMACE-MOPP regimen

International

ProMACE-MOPP regimen en Espanol

ProMACE-MOPP regimen en Francais

Business

ProMACE-MOPP regimen in the Marketplace

Patents on ProMACE-MOPP regimen

Experimental / Informatics

List of terms related to ProMACE-MOPP regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Overview

ProMACE-MOPP regimen refers to a regimen consisting of Prolix (Prednisone), Methotrexate, Adriamycin (Doxorubicin), Cyclophosphamide, Etoposide, Mustargen (Mechlorethamine), Oncovin (Vincristine), Procarbazine, Prednisone used to treat diffuse large B-cell lymphoma[1] and primary CNS lymphoma.[2]

Regimen

ProPrednisone

MMethotrexate

AAdriamycin (Doxorubicin)

CCyclophosphamide

EEtoposide

MMustargen (Mechlorethamine)

OOncovin (Vincristine)

PProcarbazine

PPrednisone

Indications

References

  1. 1.0 1.1 Sertoli MR, Santini G, Chisesi T, Congiu AM, Rubagotti A, Contu A; et al. (1994). "MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group". J Clin Oncol. 12 (7): 1366–74. PMID 7517442.
  2. 2.0 2.1 Yamanaka R, Morii K, Shinbo Y, Takeuchi S, Tamura T, Hondoh H; et al. (2005). "Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma". Ann Hematol. 84 (7): 447–55. doi:10.1007/s00277-005-1005-9. PMID 15747120.